Internal Medicine, Hematology · Rochester, NY
NPI
1235178500
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1425 Portland Ave, Box 242
Rochester, NY, 14621
Phone (585) 922-4020
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
4,461 services
Medicare patients, 2024
50
Average age 75
Drug cost, 2024
$501K
29 prescriptions
Company payments, 2025
$139
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald L Sham was code 99214 (office e&m - established), 46 times for 25 patients. In total Ronald L Sham billed 4,461 services in 11 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 46 | 25 | $71.81 | $3,303 |
| 99214 Office E&M - Established | Office | 28 | 14 | $76.91 | $2,154 |
| 99215 Office E&M - Established | Facility | 23 | 11 | $116.25 | $2,674 |
By year: 2022 $94K for 4,878 services; 2023 $90K for 4,837 services; 2024 $85K for 4,461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald L Sham prescribed most often to Medicare patients was Fabhalta (Iptacopan Hcl), with 11 prescriptions and refills. In total Ronald L Sham wrote 29 Medicare prescriptions that cost $501K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fabhalta Iptacopan Hcl | 11 | 11 | Under 11 | $498K |
Brand drugs: 17 claims; generic drugs: 12 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald L Sham $139 ($139 in general payments such as food, travel and fees) from 5 companies. The largest payer was Pfizer Inc. with $31.34.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.